The Ministry of Health wishes to thank the participants of the following working groups for guiding the design, development and implementation of the Alzheimer’s Drug Therapy Initiative:
ADTI Education Working Group
Members
Dr. Martha Donnelly, Chair, UBC-Psychiatry and Family Practice
Dr. Brenna Lynn, UBC-Continuing Professional Development & Knowledge Translation
Dr. Kathryn Bell, Geriatrician, Vancouver Coastal Health
Dr. Doug Drummond, Director of Geriatric Services, Prince George Regional Hospital
Dr. Rhonda Malyuk, Research Associate, Geriatric Psychiatry, Riverview Hospital
Elaine Unsworth, Clinical Nurse Specialist, Providence Health Care
Barbara Lindsay, Manager of Advocacy and Public Policy, Alzheimer Society of B.C.
Dr. Suzanne Taylor, Executive Director - Drug Use Optimization, Pharmaceutical Services, Ministry of Health
Ron Mattson, Project Manager, Pharmaceutical Services Division, Ministry of Health
Caroline Caiger, Technical Writer, Alzheimer’s Drug Therapy Initiative, Ministry of Health
Former Members
Betty Sinclair, former Director of Training and Education, Alzheimer Society of BC
Luke Ferdinands, former Executive Director, UBC’s Continuing Professional Development & Knowledge Translation
Kendall Ho, former Executive Director of UBC’s Continuing Professional Development & Knowledge Translation
Paul Pallan, Vice-President, Hollander Analytical Services
Dr. Duncan Robertson, Chief of Medical Staff, The Lodge at Broadmead
Terms of Reference:
provide advice and recommendations on physician education
provide advice and recommendations on types of training required
provide advice on training to inform content of future curricula
provide advice on whether training should be voluntary or mandatory
recommend agencies to provide and deliver training
estimate initial and ongoing resources required to provide training
provide advice to the ADTI Project Advisory Committee
ADTI Study Design Working Group
Members
Dr. Neena Chappell, Chair, UVic Professor of Sociology/Centre on Aging, Canada Research Chair in Social Gerontology
Dr. Lynn Beattie, Professor Emeritus, Department of Geriatric Medicine, UBC
Dr. Phillip Lee, Geriatric Medicine, St. Paul’s Hospital
Dr. Kiran Rabheru, Clinical Associate Professor and Geriatric Psychiatrist, VGH/UBC/Riverview
Dr. Claudia Jacova, Assistant Professor, Division of Neurology, UBC
Dr. Robin Hsiung, Assistant Professor, UBC Department of Neurology
Dr. Malcolm Maclure, Adjunct Professor, School of Health Information Science, UVIC and Research Officer, Ministry of Health
Ron Mattson, Project Manager and representative, Pharmaceutical Services Division, Ministry of Health
Former Members
Dr. Howard Feldman, former Professor and Head of Neurology, UBC
Dr. Robert Hogg, Director, HIV/AIDS Treatment Program, BC Centre for Excellence in HIV/AIDS
Dr. Marcus Hollander, President, Hollander Analytical Services
Paul Pallan, Vice-President, Hollander Analytical Services
Terms of Reference
provide study design consistent with outcome of the July 2006 Alzheimer’s Forum
make recommendations on eligibility criteria for Alzheimer’s Drug Therapy Initiative
develop/identify measurement tools for determining outcome from Alzheimer’s studies
develop criteria for judging outcome of Alzheimer’s drug therapy
determine data and sources of data to be collected as part of the research studies
provide advice on possible external funding sources/implementation issues
establish subgroups to assist with details of studies/implementation
recommend starting date and length of study component
call upon individuals to assist with study
ADTI Project Advisory Committee
Members
Eric Lun, Executive Director, Drug Intelligence, Pharmaceutical Services, Ministry of Health (Chair)
Jean Blake, Executive Director, Alzheimer Society of BC
Dr. Lynn Beattie, Professor Emeritus, Geriatric Medicine, UBC
Dr. Doug Drummond, Director of Geriatric Services, Prince George Regional Hospital
Ron Mattson, Project Manager, Pharmaceutical Services Division, Ministry of Health
Dr. Chris Rauscher, Ministry of Health / Vancouver Coastal Health Authority
Former Members
Dr. Elisabeth Drance, Geriatric Psychiatrist, Clinical Associate Professor, UBC
Paul Pallan, Vice-President, Hollander Analytical Services
Rosemary Rawnsley, former Executive Director, Alzheimer Society of B.C.
Terms of Reference
provide leadership for the Alzheimer’s Drug Therapy Initiative
provide advice and recommendations to Pharmaceutical Services and project management team
provide guidance to Education Working Group and Study Design Working Group
monitor the work of the Education Working Group and the Study Design Working Group
acts as a link between the initiative and other provincial bodies (e.g, BCMA, other initiatives)
